4
Shared Docs
3
Same-Page
4 / 4
Mentions
rred at=a 6.3% current yield to March 2018. Let me know if you hav= time for a call; I'm at l> .<=u> Thanks,<=> Amanda Amanda Ens</=> Director Bank of America Merril= Lynch Merrill Lynch, Pierce,=Fenner & Smith Incorporated One Bryant Park, 5th F=oor, New York, NY 10036 Phone: Mobil= </=> The power of global co=nec
inue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a
to March 2018. Let me know if you hav= time for a call; I'm at 212.449.7781 <tel:212.449.7781> .<=u> Thanks,<=> Amanda Amanda Ens</=> Director Bank of America Merril= Lynch Merrill Lynch, Pierce,=Fenner & Smith Incorporated One Bryant Park, 5th F=oor, New York, NY 10036 Phone: 212.449.7781 <tel:212.449.7781> Mobil=: 9
inue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a
available at http://www.bankofamerica.com/emaildisclaimer. If you are not the i=tended recipient, please delete this message. Am=nda Ens Director Bank of America Merrill Lynch= Merrill Lynch, Pierce, Fenner=& Smith Incorporated One Bryant Park, 5th Floor, N=w York, NY 10036 =C2 The power of global co=nections'm =
nue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a
has diminished (although will remain in pockets) but pipelines/growth remains. Ying’s top picks are CELG & REGN; Tazeen’s top picks are ACAD & RARE. Spec Pharma (-) — headwinds remain w/ Sumant’s top pick AGN given lower risk to reimbursement pressures & an underappreciated pipeline. Leverage & CF remain the
Page: HOUSE_OVERSIGHT_014523 →ist Sales Global Equities Bank of America Merrill Lynch One Bryant Park | New York, 10036 | United States T: M: The power of global connections™ Bankof America Merrill Lynch Find all Conference Events via the Following Link: https://gems.bankofamerica.com Disclaimer: This material was prepared by Sector Sp
Page: HOUSE_OVERSIGHT_014524 →Entities connected to both Bank of America and Spec Pharma

Jeffrey Epstein
PERSON
Richard Kahn
PERSON
NEW YORK NY
LOCATION
Marc Rich
PERSONAmanda
PERSON
Bloomberg L.P.
ORGANIZATIONPierce, Fenner & Smith Incorporated
ORGANIZATIONAmanda Ens
PERSONHans Mikkelsen
PERSON
Paul Volcker
PERSONChart One
ORGANIZATIONFrontier Communications
ORGANIZATIONTeva Pharma
ORGANIZATIONUS Treasury ETF
ORGANIZATIONS&P500 ETF
ORGANIZATIONInvestment Grade Supply
ORGANIZATIONInvestment Grade ETF
ORGANIZATIONFrontier Comm
ORGANIZATIONAllergan
LOCATIONPfd Return
PERSON